FREE e-zine for diagnostics pros. Subscribe now to this weekly email featuring G2's proprietary findings.
Upcoming G2 Events
MDx NEXT
April 17-19, 2012
Fairmont Copley Plaza
Boston, MA
|
April 17-19, 2012 - Boston, MA
Features & Analysis
»2011 a Mixed Year for Diagnostics Industry
The year 2011 was a tumultuous one for the diagnostics industry. Some companies were able to thrive with record revenue growth and an increasingly promising pipeline, while others saw revenues plummet and stock prices tumble under the pressure of global economic uncertainties. more…
Copyright © 2012 Kennedy Information, LLC
February 9-10, 2012 - Fort Lauderdale, FL
June 6-8, 2012 - Las Vegas, NV
Features & Analysis
»FTC Approves LabCorp’s Acquisition of Orchid Cellmark But With Conditions
Following numerous extensions of its tender offer, LabCorp (Burlington, N.C.) in early December finally received approval from the Federal Trade Commission (FTC) to acquire Orchid Cellmark, but only under certain conditions. more…
Copyright © 2012 Kennedy Information, LLC
Events
Wednesday, March 7, 2012 2:00 p.m. - 3:30 p.m.
Features & Analysis
»Congress Defers Medicare Physician Pay Cut for Two Months; Last-Minute Deal Also Extends Pathology Grandfather Protection
In last-minute maneuverings, Congressional lawmakers Dec. 23 approved an amended version of payroll tax legislation that also would defer for two months a Medicare pay cut for physicians that had been due to be implemented Jan. 1. more…
Copyright © 2012 Kennedy Information, LLC
|
G2's FREE, weekly email gives you access to G2 market analysis, regulatory changes, M&A activity, leadership moves and more on the diagnostics industry. Recent articles include:
»AMA to Congress: ‘Stop Switch to ICD-10’
Jim Curren, Editor, National Intelligence Report
The American Medical Association (AMA) is calling on Congress to halt the implementation of ICD-10 diagnosis and procedural code sets, set to begin Oct. 1, 2013, and to work with stakeholders to craft an alternative. more…
»Mitt Romney Taking Heat Over Damon Involvement
By Kimberly Scott, Managing Editor, G2 Intelligence Mitt Romney is taking a lashing once again for his role at Damon Corp., a medical testing company that paid more than $119 million in criminal and civil fines related to Medicare fraud while he served on the board. And the lashing is coming from both parties. more…
»Industry Executive Move: Roche Applied Science
Roche Diagnostics has announced that Dan Zabrowski will head Roche Applied Science in the Diagnostics Division, effective Feb. 1. He succeeds Paul Brown, who has led Roche Applied Science since September 2011. more…
More Insider
G2's FREE, daily email service brings you up-to-the-minute lab and diagnostics industry news from from across the spectrum of providers.
|
|
|